Telemedical Partners posts about topics related to chronic care management and remote patient monitoring services, devices and market information
Alerts for Respiratory Decompensation
In wake of the current COVID-19 pandemic, increased emphasis has been placed on remote monitoring of high-risk patients who have contracted the COVID-19 virus, both at home and in-clinic. Due to the nature of the virus infecting the alveoli in the lungs, monitoring of respiratory parameters—specifically respiration rate and respiratory tidal volumes-- can be a valuable tool in identifying early warning signs of respiratory decompensation. Organizations like the FDA and FCC have launched initiatives to incentivize and, in some cases, pay for telemedicine remote monitoring programs implemented by health care providers.
Respiratory Wave Forms and Reports
In an effort to help combat issues brought on by the current pandemic, toSense Inc. has made slight modifications to its core, FDA-cleared technology; the CoVa Monitoring System 2. Using its impedance-based technology, the system is able to display uniquely high-quality waveforms depicting highly accurate values of respiration rate.
Additionally, the monitoring cycle is being modified to accommodate longer battery life, giving physicians the ability to monitor patients continuously for periods of up to 8-12 hours. Automatically generated reports and a simple threshold-based alert system have been built in to the system’s gateway to notify clinicians and caregivers of negative trends in respiratory parameters.
Reports are generated frequently and can be sent to the clinician automatically. Early detection of symptoms allows clinicians and other health care professionals access to extremely valuable information, and gives them time to intervene and determine the correct next steps for treatment.
For more information on the modified CoVaä Monitoring System 2 for remote monitoring of COVID-19 patients and their respiratory parameters, please contact: Jim Shumate at Telemedical Partners.